The EMJ Podcast | Episode 183
Jonathan is joined by Elizabeth Macintyre, President-Elect and Board Member of the Biomedical Alliance, Europe; and Past President of the European Haematology Association (EHA). The pair delve into the world of haematology, focusing on Macintyre’s research towards equal access, haematological diagnostics, and her presidency during the COVID-19 pandemic.
Elizabeth Macintyre began studying medicine in 1975 at Newcastle University, UK. After internal medical and clinical laboratory haematology training at University College London (UCL), UK, she completed her PhD at St. Louis Hospital, Paris, France, on paediatric T-acute lymphoblastic leukaemia (ALL), and a postdoctoral period at Harvard University, Cambridge, Massachusetts, USA, studying oncogenic/immunogenetic interactions in T-ALL. Macintyre now co-directs the INSERM.UMR1151 Normal and Pathological Lymphoid Differentiation Team in the Necker Enfants Malades Institute in Paris. Her research interests are immature T lymphoid leukaemias and lymphomas, and minimal residual disease quantification.